Yahoo
XETRA - Delayed Quote EUR

Redcare Pharmacy NV (RDC.DE)

69.60 -4.70 (-6.33%)
At close: October 30 at 5:35:13 PM GMT+1
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,344,900
2,940,900
2,370,600
1,798,758
1,204,352
Cost of Revenue
2,625,500
2,277,800
1,824,800
1,358,375
872,566
Gross Profit
719,400
663,100
545,800
440,383
331,786
Operating Expense
716,800
692,900
584,800
457,678
401,107
Operating Income
2,600
-29,800
-39,000
-17,295
-69,321
Net Non Operating Interest Income Expense
-34,800
-18,700
-9,800
-10,410
-14,029
Pretax Income
-31,000
-47,700
-47,900
-14,348
-84,119
Tax Provision
4,200
-8,300
-1,500
-2,742
-6,473
Net Income Common Stockholders
-34,000
-37,700
-45,500
-12,041
-77,646
Diluted NI Available to Com Stockholders
-34,000
-37,700
-45,500
-12,041
-77,646
Basic EPS
-1.69
-1.87
-2.27
-0.73
-4.32
Diluted EPS
-1.69
-1.87
-2.27
-0.73
-4.32
Basic Average Shares
20,179.35
20,109.27
20,054.07
19,238.59
17,984.92
Diluted Average Shares
20,179.35
20,109.27
20,054.07
19,238.59
17,984.92
Total Operating Income as Reported
3,900
-28,500
-39,000
-17,295
-69,172
Total Expenses
3,342,300
2,970,700
2,409,600
1,816,053
1,273,673
Net Income from Continuing & Discontinued Operation
-34,000
-37,700
-45,500
-12,041
-77,646
Normalized Income
-34,000
-37,700
-45,500
-22,439.89
-74,996.85
Interest Income
-12,700
4,400
6,400
4,605
0
Interest Expense
18,900
19,900
7,800
7,998
8,504
Net Interest Income
-34,800
-18,700
-9,800
-10,410
-14,029
EBIT
-12,100
-27,800
-40,100
-6,350
-75,615
EBITDA
55,900
48,100
28,100
50,938
-36,104
Reconciled Cost of Revenue
2,625,500
2,277,800
1,824,800
1,358,375
872,566
Reconciled Depreciation
68,000
69,400
68,200
57,288
39,510
Net Income from Continuing Operation Net Minority Interest
-34,000
-37,700
-45,500
-12,041
-77,646
Total Unusual Items Excluding Goodwill
--
--
-35
12,854
-2,870
Total Unusual Items
--
--
-35
12,854
-2,870
Normalized EBITDA
55,900
48,100
28,100
38,084
-33,234
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
2,455.11
-220.85
12/31/2022 - 8/9/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: